2m 2m 2m 2m 2m 2m 2m
LONGEVERON-A (LGVN)
NASDAQ
$0.81+$0.01 (+1.75%)
Price as of Jun 23, 2026 5:25 PM EDT- $24.1MMarket Cap
- -35.48%1-Year Change
- BiotechnologyIndustry
LONGEVERON-A (LGVN)
$0.81+$0.01 (+1.75%)
LGVN | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $0.80 | ||
Change | -$0.0004 (-0.05%) | ||
Open | $0.80 | ||
High | $0.85 | ||
Low | $0.80 | ||
Previous Close | $0.80 | ||
Volume | 129,681 | ||
30-Day Average Volume | 227,965 | ||
1-Week Change | 3.90% | ||
1-Month Change | -2.46% | ||
1-Year Change | -35.48% | ||
3-Year Change | -97.87% | ||
5-Year Change | -98.95% | ||
Fundamentals | |||
Shares Outstanding | 30.1M | ||
Total Assets | $21.2M | ||
Market Cap | $24.1M | ||
Enterprise Value | $8.4M | ||
Period: QTR TTM FY | |||
Revenue | $378,000.00 | ||
Net Income | -$4.7M | ||
Free Cash Flow | -$4.4M | ||
EBIT | -$4.7M | ||
EBITDA | -$4.5M | ||
Net Working Capital | $12.5M | ||
EPS | -$0.19 | ||
Enterprise Value/EBITDA | -2 | ||
Enterprise Value/Revenue | 22 | ||
P/B | 2 | ||
P/E | -4 | ||
PEG | 0 | ||
Price/Free Cash Flow | -6 | ||
Price/Operating Cash Flow | -6 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | 1 : 10 | ||
Last Split Date | 03/27/2024 | ||
Earnings & Revenue